VNDA Return on Tangible Equity | VANDA PHARMACEUTICALS INC.

VANDA PHARMACEUTICALS INC. (VNDA) Return on Tangible Equity

2026-06-30: Return Tang Equity -256.70%.
2026-03-31: Return Tang Equity -144.60%.
2025-12-31: Return Tang Equity -104.94%.
2025-09-30: Return Tang Equity -23.57%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-256.70%
2026-03-31	-144.60%
2025-12-31	-104.94%
2025-09-30	-23.57%
2025-06-30	-17.81%
2025-03-31	-11.09%
2024-12-31	-4.45%
2024-09-30	-3.85%
2024-06-30	-2.57%
2024-03-31	-1.15%
2023-12-31	0.59%
2023-09-30	2.24%
2023-06-30	2.85%
2023-03-31	3.08%
2022-12-31	1.23%
2022-09-30	1.31%
2022-06-30	2.25%
2022-03-31	3.75%
2021-12-31	6.84%
2021-09-30	7.25%
2021-06-30	7.05%
2021-03-31	7.06%
2020-12-31	5.41%
2020-09-30	4.63%
2020-06-30	27.81%
2020-03-31	29.63%
2019-12-31	29.79%
2019-09-30	32.24%
2019-06-30	10.42%
2019-03-31	8.47%
2018-12-31	10.05%
2018-09-30	5.50%
2018-06-30	0.57%
2018-03-31	-2.25%
2017-12-31	-14.78%
2017-09-30	-13.79%
2017-06-30	-9.77%
2017-03-31	-13.19%
2016-12-31	-17.40%
2016-09-30	-32.45%
2016-06-30	-46.46%
2016-03-31	-48.17%
2015-12-31	-42.29%
2015-09-30	42.83%
2015-06-30	50.13%
2015-03-31	34.79%
2014-12-31	15.05%
2014-09-30	558.51%
2014-06-30	558.44%
2014-03-31	-506.04%
2013-12-31	-53.87%
2013-09-30	-46.27%
2013-06-30	2686.27%
2013-03-31	-7916.35%
2012-12-31	-848.41%
2012-09-30	-317.64%
2012-06-30	-191.95%
2012-03-31	-92.93%
2011-12-31	-38.52%
2011-09-30	-7.10%
2011-06-30	13.58%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-104.94%
2024-12-31	-4.45%
2023-12-31	0.59%
2022-12-31	1.23%
2021-12-31	6.84%
2020-12-31	5.41%
2019-12-31	29.79%
2018-12-31	10.05%
2017-12-31	-14.78%
2016-12-31	-17.40%
2015-12-31	-42.29%
2014-12-31	15.05%
2013-12-31	-53.87%
2012-12-31	-848.41%
2011-12-31	-38.52%
2010-12-31	25.50%
2009-12-31	-155.70%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
STANDARD BIOTOOLS INC. (LAB)	United States	$0.297B	3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)	United States	$0.296B	-21.78
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
Fulcrum Therapeutics, Inc. (FULC)	United States	$0.289B	-3.28
Contineum Therapeutics, Inc. (CTNM)	United States	$0.289B	-4.40
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
Perspective Therapeutics, Inc. (CATX)	United States	$0.284B	-3.34
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
Upstream Bio, Inc. (UPB)	United States	$0.284B	-2.42